Teladoc Health (NYSE:TDOC - Get Free Report) had its price objective boosted by Evercore ISI from $7.00 to $8.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has an "in-line" rating on the health services provider's stock. Evercore ISI's target price points to a potential downside of 9.91% from the company's current price.
Other equities research analysts have also issued research reports about the stock. Stifel Nicolaus cut their target price on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a research note on Thursday, May 1st. Citigroup cut their target price on shares of Teladoc Health from $11.00 to $8.75 and set a "neutral" rating on the stock in a research note on Friday, April 25th. Canaccord Genuity Group cut their target price on shares of Teladoc Health from $14.00 to $12.00 and set a "buy" rating on the stock in a research note on Thursday, May 1st. Bank of America cut their target price on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 28th. Finally, Jefferies Financial Group dropped their price objective on shares of Teladoc Health from $10.00 to $8.00 and set a "hold" rating on the stock in a research note on Monday, April 21st. Twelve analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $9.65.
Read Our Latest Analysis on Teladoc Health
Teladoc Health Stock Up 4.3%
NYSE:TDOC traded up $0.37 on Wednesday, reaching $8.88. The stock had a trading volume of 7,164,089 shares, compared to its average volume of 6,392,020. The company has a current ratio of 1.68, a quick ratio of 1.64 and a debt-to-equity ratio of 0.70. The company has a 50-day moving average of $7.37 and a 200 day moving average of $8.68. The stock has a market cap of $1.56 billion, a P/E ratio of -1.50 and a beta of 1.84. Teladoc Health has a 12-month low of $6.35 and a 12-month high of $15.21.
Insider Buying and Selling
In related news, insider Fernando M. Rodrigues sold 4,174 shares of the firm's stock in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $6.91, for a total transaction of $28,842.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Carlos Nueno sold 3,958 shares of the company's stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total transaction of $27,151.88. Following the completion of the sale, the insider owned 17,645 shares of the company's stock, valued at approximately $121,044.70. This trade represents a 18.32% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 18,656 shares of company stock worth $128,189. Corporate insiders own 0.58% of the company's stock.
Institutional Investors Weigh In On Teladoc Health
Hedge funds have recently made changes to their positions in the company. Golden State Wealth Management LLC lifted its position in Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock worth $27,000 after buying an additional 1,690 shares in the last quarter. National Bank of Canada FI lifted its position in Teladoc Health by 79.4% in the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock worth $28,000 after buying an additional 1,581 shares in the last quarter. SVB Wealth LLC purchased a new stake in Teladoc Health in the 1st quarter worth approximately $37,000. Sterling Capital Management LLC lifted its position in Teladoc Health by 776.7% in the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock worth $42,000 after buying an additional 4,101 shares in the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S purchased a new stake in Teladoc Health in the 1st quarter worth approximately $50,000. Hedge funds and other institutional investors own 76.82% of the company's stock.
About Teladoc Health
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Stories
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
